Product

Hypobetalipoproteinemia genetic screening

1 clinical trial

1 indication

Clinical trial
HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism
Status: Active (not recruiting), Estimated PCD: 2022-01-07